Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-04-17

Clinical Trial Update: A Study in Prevention of Re-emergence of Depression Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update on preventing the re-emergence of depression symptoms in Major Depressive Disorder; the study completed and results were posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eli Lilly and Company | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2018-04-17